Estrogen Receptors and Platelet-Activating Acetylhydrolase Activity in the Pathogenesis of Systemic Lupus Erythematosus
Pharmacology · 2025
DOI: 10.1159/000543797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology, 2025. Verfasst von Akira Sato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutritional Science, Faculty of Human Life Science, Miyagi Gakuin Women's University, Sendai, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Estrogen Receptor alpha, 1-Alkyl-2-acetylglycerophosphocholine Esterase, Estrogen Receptor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects various body systems, including the skin and facial features. Estrogen promotes lupus in human and mouse models of SLE. In this study, we conducted an in vivo study to investigate the relationship between two estrogen receptors (ERα and ERβ) and platelet-activating factor acetylhydrolase (PAF-AH) on the symptoms of SLE.
Methods
Skin and facial features, serum PAF-AH activity, tumor-necrosis factor-alpha (TNF-α), and anti-double stranded DNA (anti-dsDNA) antibody titer, all of which are central to the classification and pathogenesis of SLE, were measured in SLE model mice injected with various ER antagonists.
Results
In SLE mice, the injection of an ERβ antagonist 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-α]pyrimidine-3-yl]-phenol induced the expression of facial erythema (especially around a cheek). The injection of an ERα/β antagonist tamoxifen induced hair-loss on the head and the neck. The injection of an ERα antagonist methylpiperidino pyrazole or tamoxifen increased PAF-AH activity and decreased TNF-α levels and anti-dsDNA antibody in mouse serum.
Conclusions
The activation of ERα and inactivation of ERβ can cause inflammatory and cutaneous symptoms of SLE, respectively, implying that ERα antagonists and/or ERβ agonists can be useful for the prevention and treatment of SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food and Nutritional Science, Faculty of Human Life Science, Miyagi Gakuin Women's University, Sendai, Japan.
- Faculty of Pharmacy, Iryo Sosei University, Iwaki, Japan.
Zitieren
APA
Sato, A., Ogawa, Y., Yabuki, A., Sato, G., Nemoto, H., Ohira, M., & Sato, A. (2025). Estrogen Receptors and Platelet-Activating Acetylhydrolase Activity in the Pathogenesis of Systemic Lupus Erythematosus. Pharmacology. https://doi.org/10.1159/000543797
Vancouver
Sato A, Ogawa Y, Yabuki A, Sato G, Nemoto H, Ohira M, et al. Estrogen Receptors and Platelet-Activating Acetylhydrolase Activity in the Pathogenesis of Systemic Lupus Erythematosus. Pharmacology. 2025. doi:10.1159/000543797
BibTeX
@article{Sato2025,
author = {Sato, Akira and Ogawa, Yuta and Yabuki, Ayano and Sato, Genta and Nemoto, Hina and Ohira, Makoto and Sato, Akira},
title = {Estrogen Receptors and Platelet-Activating Acetylhydrolase Activity in the Pathogenesis of Systemic Lupus Erythematosus},
journal = {Pharmacology},
year = {2025},
doi = {10.1159/000543797}
}
EUVIMED